Advanced Therapies: Innovations in CMC Conference

Solutions for CMC challenges in the development and commercialization of cell therapy, gene therapy, and gene editing products.

Back to Agenda

Opening Remarks and Keynote Address

Owner

KM Intel LLC, United States

Opening Remarks and Keynote Address

Peter Marks, MD, PHD

Eli Lilly and Company, United States

Senior Vice President, Molecule Discovery and Head of Infectious Disease

Have an account?